Days after the Kerala government was questioned about its links to the U.S. company Sprinklr regarding the transmission of data from people under surveillance for COVID-19, the government released documents relating to the contract. Eight documents posted on the State Government website include the order form, the service contract, Sprinklr`s declaration of confidentiality, the confidentiality agreement and two confirmation letters written on April 11 and 12. The insurance under oath also shows that the Kerala government agreement with Sprinklr dilutes the rights of the people. He said the contract should not get the amount of compensation that individuals in case of privacy violations or abuse of information. Details of the agreement have been published on the website. The agreement signed on April 2 expires on September 24. Depending on the deal, the data can be collected from March 25 to September 24. Previously, Sprinkler also mentioned data protection in a letter to the IT secretary. State Information Technology Department Secretary and Officer of Special Duty to Chief Minister M Sivasankaran had signed agreement with New Jersey-based Sprinklr.
The pact was drawn up without the approval of the legal and financial services. The end date of the transfer is earlier than (i) September 24, 2020 and/or (ii) the end of the COVID 19 pandemic, as agreed by consensus between the parties. It is expected that the validity of the licence will be extended by the mutual written agreement of the parties (a „delay of extension“). Data retention and support conditions apply under the Silver and Standard or Sprinklr Service Level Agreement (SLA) categories. The Kerala government has denounced the agreement reached with the American technology company Sprinklr on the collection and management of health data of Covid 19 patients and isolated patients in the state. The confidentiality agreement, which the government had previously cited as evidence of data protection guarantees, states in a section with the inscription „Confidentiality“: concerns have been expressed that the liability of health data in a U.S. company endangers the privacy of Covid 19 patients and quarantined individuals. Opposition parties have called for the agreement to be repealed.